New HPV vaccine trial tests fewer shots for teens
NCT ID NCT06632912
Summary
This study is testing a new HPV vaccine to see if it works as well with different numbers of shots for different age groups. It will enroll 1,800 girls and women aged 9 to 35. The main goal is to compare the body's immune response from a 2-dose schedule in younger girls to a 3-dose schedule in older participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Daiyue District Center for Disease Control and Prevention
Tai’an, Shandong, China
-
Liaocheng Center for Disease Control and Prevention
Liaocheng, Shandong, China
-
Shanxian Center for Disease Control and Prevention
Heze, Shandong, China
Conditions
Explore the condition pages connected to this study.